Artificial Intelligence technologies in healthcare have expanded well beyond initial uses in imaging and diagnostics. AI is now involved in many areas, such as virtual assistants handling patient scheduling, symptom checkers supporting early diagnoses, clinical decision support systems helping physicians, and automation tools managing front-office tasks like appointment reminders and call handling.
Investment in AI for healthcare is increasing. Organizations like Hooper Lundy & Bookman have observed rapid growth in funding, showing confidence that AI can improve healthcare delivery and efficiency. Yet, this growth raises concerns about reliability, transparency, algorithmic bias, patient privacy, and regulatory compliance.
Handling protected health information requires adherence to U.S. privacy laws like the Health Insurance Portability and Accountability Act (HIPAA). Regulators are also adapting rules to balance technological progress with patient safety and legal responsibility.
HIPAA continues to govern how protected health information (PHI) is used and disclosed when AI tools are involved. Developers and healthcare providers must ensure patient data used in AI training or deployment is either de-identified or managed under strict consent and privacy rules. Contracts with vendors need close review to confirm compliance with data usage, storage, and purpose.
The U.S. Department of Health and Human Services (HHS) has stressed that privacy laws apply fully to AI, with extra attention to protecting sensitive data from breaches or misuse.
Partnerships between healthcare providers, IT developers, and vendors in AI innovation must follow the Federal Anti-Kickback Statute. This law forbids payment arrangements designed to encourage referrals or use of services.
If third parties pay developers to create AI software that promotes specific drugs or lab tests, it could violate this statute. Healthcare managers and IT leaders need to review contracts carefully to ensure transparency in financial dealings.
Not every AI system in healthcare is regulated as a medical device. The FDA clarified in guidance released in September 2022 that Clinical Decision Support Software (CDSS) allowing clinicians to independently understand AI recommendations generally isn’t classified as a regulated device. However, software that directly affects clinical decisions without provider review may need approval.
This approach lets innovation continue while providing safeguards against malpractice from overreliance on AI outputs.
The White House has proposed the AI Bill of Rights to establish principles of transparency, privacy, and non-discrimination in AI use. Though still developing, this framework aims to give individuals more control over AI’s effects on their health.
At the same time, some states have passed laws addressing specific AI applications. For example, Massachusetts has enacted legislation overseeing AI use in mental health services, focusing on informed consent and approval procedures. These laws tailor governance to particular clinical areas where AI is applied.
The Office of the National Coordinator for Health Information Technology (ONC) has proposed regulations to improve transparency around AI algorithms and require real-world testing before full deployment. This aims to promote fairness and safety, guiding developers to detect and reduce bias.
Healthcare administrators and IT managers should watch these developments closely, as compliance audits may soon become common.
The American Medical Association (AMA) adopted its Policy for Augmented Intelligence in 2018, stating AI should support—not replace—clinical judgment. AMA guidelines focus on ethical AI integration, patient safety, and protecting consumers.
Other groups like the Consumer Technology Association and the National Institute of Standards and Technology (NIST) provide frameworks for managing risk and encouraging reliable AI. NIST’s AI Risk Management Framework, released in January 2023, offers voluntary guidance on identifying and mitigating AI risks, especially regarding fairness and transparency.
AI’s impact on healthcare is visible in administrative workflows and patient communication. AI-based phone automation and answering services reduce front-office workload, improve patient engagement, and speed up responses.
Companies such as Simbo AI provide AI-driven phone systems that handle patient calls, appointment scheduling, and call triage without human operators. This helps administrators and IT managers by:
These tools must comply with HIPAA to secure patient data transmitted or stored on their platforms. Transparency about AI’s involvement in calls is increasingly expected to maintain patient trust.
Automation also extends to clinical workflow tasks such as optimizing appointment scheduling, sending reminders, and managing billing. These features can boost efficiency, decrease no-shows, and improve revenue cycles.
Healthcare IT leaders should assess vendors for compliance, data security, and flexibility in adapting to rule changes. Solutions like Simbo AI are designed with healthcare standards in mind, providing automation options that respect privacy and regulations.
As AI influences clinical decisions more, new questions arise about responsibility and malpractice risk. Clinicians must understand that using AI advice does not remove their legal obligation to exercise independent judgment.
Both HHS and AMA caution that blind trust in AI could increase malpractice risks if AI recommendations lead to harm. Administrators should train providers to critically assess AI tools and document how AI inputs affected their decisions.
Bias in AI algorithms is also a concern. If algorithms are trained on limited or unrepresentative data, they may produce unfair results impacting vulnerable groups.
To address this, proposed changes to the Affordable Care Act aim to prohibit discriminatory AI use in health programs and insurance.
Mitigating bias requires testing, ongoing monitoring, and transparent methods. ONC’s proposed certification rules and NIST’s guidance offer frameworks to identify and lessen bias effects.
With the policy environment changing, medical practice leaders should proactively manage AI governance. Important steps include:
AI integration offers benefits in patient care and practice management. At the same time, ongoing legislative efforts in the U.S. aim to ensure AI is developed and used responsibly, with attention to transparency, privacy, and ethics. Healthcare administrators and IT managers will need to understand and follow these regulations to deploy AI tools effectively and maintain patient trust in a growingly automated system.
AI has seen an exponential rise in interest and investment in healthcare, contributing to advancements in areas such as patient scheduling, symptom checking, and clinical decision support tools.
Existing healthcare regulatory laws, such as the Health Insurance Portability and Accountability Act (HIPAA), still apply to AI technologies, guiding their use and ensuring patient data privacy.
AI developers require vast amounts of data, so any use of patient data must align with privacy laws, focusing on whether data is de-identified or if protected health information (PHI) is involved.
Remuneration from third parties to health IT developers for integrating AI that promotes their services can violate the Anti-Kickback Statute, especially involving pharmaceuticals or clinical laboratories.
The FDA has established guidance on Clinical Decision Support Software to clarify which AI tools are considered medical devices, based on specific criteria that differentiate them from standard software.
Practitioners using AI for clinical decisions may face malpractice claims if an adverse outcome arises, as reliance on AI could be seen as deviating from the standard of care.
Legislative efforts, such as the White House’s AI Bill of Rights, aim to establish guidelines for AI using principles like data privacy, transparency, and non-discrimination.
Covered entities must assess how PHI is used in AI contracts, ensuring compliance with laws and determining the scope of data vendors can use for development.
AI systems risk generating biased outcomes due to flawed algorithms or non-representative datasets, prompting regulatory attention to prevent unlawful discrimination.
The ONC’s Health Data, Technology and Interoperability Proposed Rule sets standards for AI technologies to ensure they are fair, safe, and effective, focusing on transparency and real-world testing.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
